Elizabeth Holmes has found another way to control the frame. You Can See Everything, directed by Nathan Fielder and Lance Oppenheim, follows Holmes and her partner, Billy Evans, at home with their children around a month before Holmes reported to prison. She invited the cameras inside to reframe her narrative — a familiar strategy from someone known for dishonesty and effective manipulation.
Holmes dropped out of Stanford University in 2003 to run Theranos, the diagnostics company she founded. She claimed Theranos had invented a way to run more than 100 diagnostic tests using only a few drops of blood, then raised hundreds of millions of dollars from investors who accepted the promise before the evidence.
By 2014, Theranos was valued at $9 billion. Forbes named Holmes the youngest self-made female billionaire, and she was said to be worth $4.5 billion at age 30. Her public image presented a work-obsessed founder who cared about health care and lived modestly, which made the collapse feel less like a failed company than a failed national fantasy.
The performance behind the company
Former employees raised concerns about Theranos tests in 2015, and an investigation by the Wall Street Journal brought those concerns into public view. MIT Technology Review named Theranos one of the biggest technology failures of 2015, while Holmes’s worth was revised to $0 by 2016.
A government report that year said the Theranos lab struggled with basic procedures and gave patients results the company knew could be wrong. In 2018, Theranos, Holmes, and Ramesh Balwani were charged with massive fraud. Holmes received a sentence of over 11 years in prison in 2022 and began serving it in May 2023; she is serving her federal sentence in Texas.
The documentary now turns that history into a question about authorship. Holmes told The New York Times in 2023 that actors portraying her were “playing a character I created.” She later denied saying actors created the character of her, insisting instead that “the actors created the character themselves.”
That distinction matters because Holmes’s image was never an accidental byproduct of Theranos. It was cultivated through clothing, controlled appearances, a carefully repeated mission, and the suggestion that personal sacrifice proved technical seriousness. The home documentary offers another controlled setting, this time after conviction and before prison, when sympathy and self-explanation can compete with the record.
The people who could not look away
Holmes and Evans recorded most of their media interviews, but they could not produce the recordings when asked. The missing tapes do not prove a new claim about the documentary, but they fit the larger pattern: control the encounter, preserve the useful version, and leave everyone else arguing over what happened.
Tyler Shultz, a former Theranos research engineer and whistleblower, described Holmes’s influence with uncomfortable clarity. He said he could “have a five-minute conversation with her and walk away feeling like my work was changing the world.” Later, during a moment that exposed the gap between presentation and reality, he said, “That is not the device!”
Shultz has also said he was so afraid of Theranos that he slept with a knife under his pillow. He believes Holmes was abused by Balwani, her former boyfriend and Theranos executive, but says being a victim does not excuse her conduct. Both facts can exist at once, which is less satisfying than a clean villain story and more useful.
Holmes’s living arrangements also complicate the modest-founder mythology. In 2014, she lived in a two-bedroom Palo Alto condo, according to a description by The New Yorker, while actually living in an Atherton mansion with Sunny Balwani. During her trial, she lived on the Green Gables estate in Woodside, Calif., which was listed for $135 million; she and Evans now live in a San Diego rental estimated at $5.8 million.
Fielder said, “I still am not sure to this day what I experienced.” That uncertainty may be the documentary’s strongest subject, even if Holmes intended something else. The story of Theranos already had billion-dollar valuations, fraud charges, a prison sentence, and patients receiving results that could be wrong. It did not need another performance — but performance is what made Holmes’s story travel.
You Can See Everything earned an estimated $15 million in its opening weekend. The audience is not simply watching a disgraced executive revisit her past; it is watching the machinery of fascination keep working after the company is gone. Theranos promised that a few drops could reveal everything. The documentary asks what remains hidden when the cameras are invited in.
Based on
